Immunotherapy in Pediatric Hematologic Malignant Neoplasms
Childhood acute leukemia has achieved tremendous treatment outcome improvement over the past several decades. Given that pediatric leukemia remains the most common type of childhood malignant tumors, there are still unmet needs in relapsed/refractory diseases. Moreover, reducing the toxic adverse ef...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Society of Pediatric Hematology-Oncology
2020-04-01
|
| Series: | Clinical Pediatric Hematology-Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.15264/cpho.2020.27.1.14 |